Efficacy of Ozanimod versus Interferon beta-1a by DMT treatment experience and EDSS categorisation from a multicenter, randomised, double-blind, phase-3 study of relapsing Multiple Sclerosis

Authors
Category Primary study
JournalEuropean Journal of Neurology
Year 2018
This article has no abstract
Epistemonikos ID: 50c453cb2f282be79d6767de492d9e8fb7eee7f9
First added on: Feb 09, 2025